T4 gp32 Protein, 500µg
To Order Contact us: lieven@wlsolutions.be
Recombinant HIV-2 gp32 Protein, Untagged, E.coli-500ug |
||
QP12268-EC-500ug | 500ug | EUR 795.6 |
HIV-2 gp32 |
||
hiv-134 | 100µg | EUR 165 |
Description: Recombinant HIV-2 gp32 |
HIV-2 gp32 HRP |
||
hiv-137 | 100µg | EUR 275 |
Description: Recombinant HIV-2 gp32, Horseradish Peroxidase Labled |
HIV-2 gp32 Biotin |
||
hiv-135 | 100µg | EUR 275 |
Description: Recombinant HIV-2 gp32, Biotin Labeled |
Recombinant HIV-2 gp32 |
||
7-07723 | 100µg | Ask for price |
Recombinant HIV-2 gp32 |
||
7-07724 | 500µg | Ask for price |
Recombinant HIV-2 gp32 |
||
7-07725 | 1000µg | Ask for price |
HIV-2 gp32 (Recombinant) |
||
22060218-1 | 100 µg | EUR 264.47 |
Recombinant (E.Coli) HIV-2 gp32 |
||
RP-568 | 100 ug | EUR 343.2 |
T4 UvsY Protein - 1000µg |
||
3577 | 500μg | EUR 1925 |
Description: UvsY is the phage T4 recombination mediator protein, and structural and biophysical studies provide insights into its role in T4 homologous recombination. During T4 homologous recombination, the UvsX recombinase must compete with the prebound gp32 single-stranded binding protein for DNA-binding sites and T4 UvsY Protein stimulates this filament nucleation event. UvsY is a 15.8-kDa protein with properties that are consistent with its role as mediator; it stimulates the DNA-dependent ATPase activity of UvsX, lowers the critical concentration of UvsX that is required for activity, and promotes strand exchange. UvsY efficiently promotes the UvsX-catalyzed strand invasion reaction by recruiting to ssDNA–gp32 complexes, promotes the release of gp32, and favors the binding of UvsX.Product IncludesT4 UvsY protein10X T4 UvsY Reaction Bufferr |
HIV-2 gp32 recombinant antigen |
||
00173-V-01mg | 0,1 mg | EUR 321 |
Description: HIV-2 gp32 recombinant antigen. . |
HIV-2 gp32 recombinant antigen |
||
00173-V-1000ug | 1000 ug | EUR 1539 |
Description: HIV-2 gp32 recombinant antigen. . |
HIV-2 gp32 recombinant antigen. . |
||
00173-V-100ugvial | 100ug/vial | EUR 150 |
Description: HIV-2 gp32 recombinant antigen. . |
HIV-2 gp32 recombinant antigen. . |
||
00173-V | 1 MG | EUR 850 |
Recombinant HIV-2 gp32, Biotin Labeled |
||
7-07726 | 100µg | Ask for price |
Recombinant HIV-2 gp32, Biotin Labeled |
||
7-07727 | 500µg | Ask for price |
Recombinant HIV-2 gp32, Biotin Labeled |
||
7-07728 | 1000µg | Ask for price |
HIV-2 gp32, Biotin Labeled (Recombinant) |
||
22060219-1 | 100 µg | EUR 365.12 |
Recombinant Escherichia phage RB69 Gp32 (32) |
||
CSB-EP4076GQXa0 | 9641 mg | Ask for price |
Recombinant (E.Coli) HIV-2 gp32, Biotin Labeled |
||
RP-569 | 50 ug | EUR 343.2 |
Recombinant HIV-2 gp32, Horseradish Peroxidase Labled |
||
7-07729 | 100µg | Ask for price |
Recombinant HIV-2 gp32, Horseradish Peroxidase Labled |
||
7-07730 | 500µg | Ask for price |
Recombinant HIV-2 gp32, Horseradish Peroxidase Labled |
||
7-07731 | 1000µg | Ask for price |
HIV-2 gp32, Horseradish Peroxidase Labeled (Recombinant) |
||
22060220-1 | 100 µg | EUR 365.12 |
Recombinant (E.Coli) HIV-2 gp32, Horseradish Peroxidase Labled |
||
RP-570 | 50 ug | EUR 343.2 |
Lambda DNA (0.5µg/µl), 500µg |
||
NN1402 | each | Ask for price |
T4 Gene 32 Protein |
||
M1232-100 | each | EUR 280.8 |
T4 Gene 32 Protein |
||
E040 | 100 μg | EUR 50 |
Description: T4 Gene 32 Protein is a single-stranded DNA (ssDNA) binding protein which is required for T4 bacteriophage replication, recombination and repair. T4 Gene 32 Protein binds cooperatively and stoichiometrically to ssDNA effectively stabilizing it. This protein enhances DNA synthesis activities, including PCR amplification and DNA sequencing. |
T4 DNA Ligase protein |
||
30R-2898 | 250 units | EUR 268.8 |
Description: Purified recombinant Human T4 DNA Ligase protein |
OPCA04293-1MG - T4 Lysozyme Recombinant Protein (Bacteriophage T4) |
||
OPCA04293-1MG | 1mg | EUR 1977 |
OPCA04293-100UG - T4 Lysozyme Recombinant Protein (Bacteriophage T4) |
||
OPCA04293-100UG | 100ug | EUR 586 |
OPCA04293-20UG - T4 Lysozyme Recombinant Protein (Bacteriophage T4) |
||
OPCA04293-20UG | 20ug | EUR 400 |
Lambda DNA (dam-) (dcm-) (0.5µg/µl), 500µg |
||
NN1401 | each | Ask for price |
Human Golgi Protein 73 (GP73) Protein |
||
20-abx066897 |
|
|
Mouse Golgi Protein 73 (GP73) Protein |
||
20-abx066898 |
|
|
HIV1 gp160 protein |
||
30-1836 | 100 ug | EUR 1669.2 |
Description: Purified Recombinant HIV1 ADA Envelope Glycoprotein gp160 |
HIV1 gp120 protein |
||
30-AH86 | 100 ug | EUR 1585.2 |
Description: Purified full length recombinant HIV1 gp120 protein-IIIB strain |
HIV2 gp105 protein |
||
30-015001 | 100 ug | EUR 159.6 |
Description: Purified recombinant HIV2 gp105 protein |
HIV1 gp120 protein |
||
30-12001-2 | 100 ug | EUR 846 |
Description: Purified recombinant HIV1 gp120 protein |
HIV1 gp120 protein |
||
30-12001-4 | 1 mg | EUR 7546.8 |
Description: Purified recombinant HIV1 gp120 protein (HRP) |
HIV 1 gp160 Protein |
||
abx060587-1mg | 1 mg | EUR 1128 |
HIV-1 gp41,gp120 Protein |
||
20-abx260288 |
|
|
Human Golgi membrane protein GP73 Protein |
||
abx060158-100ug | 100 ug | EUR 1362 |
Melanoma (gp100) Protein |
||
20-abx263540 |
|
|
Mouse Golgi Protein 73 (GP73) Protein (Active) |
||
20-abx651342 |
|
|
HIV1 gp41 protein |
||
30R-AH026 | 1 mg | EUR 1442.4 |
Description: Purified recombinant HIV1 gp41 protein |
HIV2 gp36 protein |
||
30R-AH030 | 100 ug | EUR 418.8 |
Description: Purified recombinant HIV2 gp36 protein |
HIV2 gp36 protein |
||
30-AH25 | 1 mg | EUR 392.4 |
Description: Purified recombinant HIV2 gp36 protein |
HIV1 gp41 protein |
||
30-AH26 | 1 mg | EUR 396 |
Description: Purified recombinant HIV1 gp41 protein |
HIV2 gp36 protein |
||
30-AH82 | 100 ug | EUR 356.4 |
Description: Purified recombinant HIV2 gp36 protein |
HIV2 gp36 protein |
||
30-AH82S | 100 ug | EUR 477.6 |
Description: Purified recombinant HIV2 gp36 protein |
HIV1 gp41 protein |
||
30-AH83 | 100 ug | EUR 236.4 |
Description: Purified recombinant HIV1 gp41 protein |
HIV2 gp36 protein |
||
30-034001 | 100 ug | EUR 690 |
Description: Purified recombinantl HIV2 gp36 protein |
HIV1 gp41 protein |
||
30-039001 | 100 ug | EUR 159.6 |
Description: Purified recombinant HIV1 gp41 protein |
HIV1 gp41 protein |
||
30-039001F | 1 mg | EUR 2991.6 |
Description: Purified HIV1 gp41 protein |
HIV1 gp41 protein |
||
30-2022 | 1 mg | EUR 1052 |
Description: Purified recombinant HIV1 gp41 protein |
HTLV1 gp46 protein |
||
30-041001 | 100 ug | EUR 548.4 |
Description: Purified recombinant HTLV1 gp46 protein |
HTLV1 gp46 protein |
||
30-042001F | 1 mg | EUR 418.8 |
Description: Purified recombinant HTLV1 protein (gp46) |
HTLV1 gp46 protein |
||
30-043001F | 100 ug | EUR 770.4 |
Description: Purified recombinant HTLV1 gp46 protein |
HTLV1 gp21 protein |
||
30-044001 | 100 ug | EUR 758.4 |
Description: Purified recombinant HTLV1 gp21 protein |
HTLV1 gp21 protein |
||
30-044001-LQ | 100 ug | EUR 758.4 |
Description: Purified recombinant HTLV1 gp21 protein |
HIV-1 gp120 MN Protein |
||
20-abx260008 |
|
|
HIV-1 gp120 CM Protein |
||
20-abx260013 |
|
|
HIV-1 gp41 Protein |
||
20-abx260275 |
|
|
HIV-1, gp41 Protein |
||
abx061536-1mg | 1 mg | EUR 1161.6 |
HIV-2, gp36 Protein |
||
abx061537-1mg | 1 mg | EUR 1161.6 |
HTLV I gp21 Protein |
||
abx060598-100ug | 100 ug | EUR 811.2 |
HTLV I gp46 Protein |
||
abx060599-100ug | 100 ug | EUR 811.2 |
HIV-2, gp36 Protein |
||
abx069859-1mg | 1 mg | EUR 1312.8 |
gp64 protein antibody |
||
10R-6618 | 100 ug | EUR 424.8 |
Description: Mouse monoclonal gp64 protein antibody |
gp64 protein antibody |
||
10R-6621 | 100 ug | EUR 648 |
Description: Mouse monoclonal gp64 protein antibody |
"P53 , B-P3; IgG2a; Azide free; 500µg/500µl |
||
M853040005 | 1 unit | EUR 607.79 |
HTLV-1 gp21 Protein |
||
20-abx260284 |
|
|
HTLV-1 gp46 Protein |
||
20-abx260285 |
|
|
HTLV1 gp21 protein (HRP) |
||
65-044002 | 50 ug | EUR 853.2 |
Description: Purified recombinant HTLV1 gp21 (HRP) |
Rat Glycoprotein 130 (gp130) Protein |
||
20-abx069730 |
|
|
HIV-2 gp36 397 a.a Protein |
||
20-abx260283 |
|
|
HTLV1 gp21 protein (FITC) |
||
65-044003 | 50 ug | EUR 418.8 |
Description: Purified recombinant HTLV1 gp21 (FITC) |
HIV2 gp105 ROD protein |
||
30-015001F | 100 ug | EUR 159.6 |
Description: Purified recombinant HIV2 gp105 protein |
Mouse Glycoprotein 130 (gp130) Protein |
||
20-abx167413 |
|
|
Human Glycoprotein 130 (gp130) Protein |
||
20-abx066881 |
|
|
Human Glycoprotein 130 (gp130) Protein |
||
20-abx066882 |
|
|
HIV1 gp41 MN protein (HRP) |
||
65-040002 | 50 ug | EUR 715.2 |
Description: Purified recombinant HIV1 gp41 MN (HRP) |
HIV Type-O gp41 Protein |
||
20-abx260281 |
|
|
HIV1 gp41 MN protein (FITC) |
||
65-040003 | 50 ug | EUR 418.8 |
Description: Purified recombinant HIV1 gp41 MN (FITC) |
GP120 Recombinant Protein |
||
96-365 | 0.1 mg | EUR 619.8 |
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
GP120 Recombinant Protein |
||
96-366 | 0.1 mg | EUR 619.8 |
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
GP120 Recombinant Protein |
||
96-367 | 0.1 mg | EUR 714.3 |
Description: Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses.Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds. |
HIV-1 gp120 LAV Protein |
||
20-abx260011 |
|
|
HIV-1 gag p17, p24, gp120 Protein |
||
20-abx260274 |
|
|
Recombinant HIV-1 gp120 and gp41 Protein |
||
VAng-Lsx04597-1mg | 1 mg | EUR 637.2 |
Description: HIV type 1 Glycoprotein 120 and 41, recombinant protein from E. coli. |
OPNB00030-100UG - EBV gp125 protein |
||
OPNB00030-100UG | 100ug | EUR 648 |
OPNB00030-500UG - EBV gp125 protein |
||
OPNB00030-500UG | 500ug | EUR 2471 |
OPNB00031-100UG - EBV gp125 protein |
||
OPNB00031-100UG | 100ug | EUR 648 |
OPNB00031-500UG - EBV gp125 protein |
||
OPNB00031-500UG | 500ug | EUR 2471 |
HIV 1 Envelope gp41 Protein |
||
abx060584-05mg | 0.5 mg | EUR 1128 |
HIV 1 Envelope gp41 Protein |
||
abx060585-100ug | 100 ug | EUR 1296 |
HIV 2 Envelope gp36 Protein |
||
abx060591-1mg | 1 mg | EUR 1629.6 |
HIV 2 Envelope gp36 Protein |
||
abx060592-100ug | 100 ug | EUR 1279.2 |
VCAP18/GP125 fusion protein |
||
30-1296 | 1 mg | EUR 4177.2 |
Description: Purified recombinant VCAP18/GP125 fusion protein |
HIV2 gp105 ROD protein (FITC) |
||
65-015003F | 1 mg | EUR 457.2 |
Description: Purified HIV2 gp105 protein (ROD) (FITC) |
Recombinant HIV gp41, O Group gp41, gp36 Protein |
||
VAng-0540Lsx-inquire | inquire | Ask for price |
Description: HIV Chimeric Recombinant protein containing gp41 (a.a. 546 to 692), O Group gp41 Segment, gp36 Segment (a.a. 591 to 617), recombinant protein from E. coli. |
OPMA04779-1MG - HIV-1 gp120 Protein |
||
OPMA04779-1MG | 1mg | EUR 1099 |
Synthetic HIV-2 gp36 Protein |
||
20-abx260067 |
|
|
HIV2 gp105 ROD protein (biotin) |
||
65-015005 | 50 ug | EUR 289.2 |
Description: Purified recombinant HIV2 gp105 ROD (biotin) |
HIV-1 [HIV-1/Clade C (16055)] GP120 Protein, His Tag |
||
GP5-V15224 | 1mg | EUR 374.5 |
Description: HIV-1 [HIV-1/Clade C (16055)] GP120, His Tag (GP5-V15224) is expressed from human 293 cells (HEK293). It contains AA Thr 34 - Arg 506 (Accession # ABL67444.1). |